İçeriğe geç
akaturk Akademik ölçüm
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 104
YÖKSİS104 OpenAlex0
Proje 5
Kitap 22
Bildiri 106

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 19
h-indeks 8 Türkiye yüzdelik dilimi: 80 Üniversitesinde h-indekse göre 107. / 866
i10-indeks
8
Toplam atıf
157
Türkiye’de üst %26
Makale başına
8,3
FWCI
2,02
1,00 = dünya ortalaması
Dünyada üst %1
1
Dünyada üst %10
3

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 47
  • Q1 10
  • Q2 14
  • Q3 15
  • Q4 8
WoS (JCR) 43
  • Q1 4
  • Q2 8
  • Q3 10
  • Q4 21
TR Index TR Index

28 makale

OpenAlex atıf yüzdelik
  • Üst %1 1
  • Üst %10 3
  • Ort. 56.9%
  • n 19
Diğer sayımlar

Scopus (SJR)

  • Özet hariç 46 Q1 9 Q2 14 Q3 15 Q4 8
  • YÖKSİS satırı 48

WoS (JCR)

  • Özet hariç 42 Q1 3 Q2 8 Q3 10 Q4 21
  • YÖKSİS satırı 44

TR Index

  • YÖKSİS satırı 29 makale

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

43 dergi

Makale listesi

  1. 2025 Home Spirometry for Post-COVID Recovery: A Clinical Validation Study of an Ultrasonic Device Diagnostics DOI 10.3390/diagnostics15111396 YÖKSİS OpenAlex 15.9%
  2. 2025 Slow gait speed is associated with frailty, activities of daily living and nutritional status in in-patient pulmonology patients Aging Clinical and Experimental Research DOI 10.1007/s40520-025-03040-5 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %1 OpenAlex 99.6%
  3. 2025 Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis Annals of Thoracic Medicine DOI 10.4103/atm.atm_213_24 YÖKSİS SJR Q1 JCR Q3
  4. 2025 Impact of nutritional status and pulmonary function on short- and long-term overall survival in hemodialysis patients PLOS ONE DOI 10.1371/journal.pone.0317510 YÖKSİS SJR Q1 JCR Q1
  5. 2025 Analysis of inhaler treatment in patients with asthma and chronic obstructive pulmonary disease (COPD): The INTEDA-2 study Eurasian Journal of Pulmonology DOI 10.14744/ejp.2025.14428 YÖKSİS TR Index SJR Q4 JCR Q4
  6. 2025 Diagnostic Performance of Sarcopenia Screening Tests in Chronic Lung Disease Patients The Eurasian Journal of Medicine DOI 10.5152/eurasianjmed.2025.25806 YÖKSİS TR Index SJR Q3 JCR Q2 OpenAlex 76.2%
  7. 2024 Electronic cigarette use and consumption patterns in medical university students Frontiers in Public Health DOI 10.3389/fpubh.2024.1403737 YÖKSİS SJR Q1 JCR Q1
  8. 2024 Assessment of quality of life in IPF Patients: a multicenter observational study Sarcoidosis Vasc Diffuse Lung Dis DOI 10.36141/svdld.v41i3.15805 YÖKSİS SJR Q3
  9. 2024 Comparison of BAP65, DECAF, PEARL, and MEWS Scores in Predicting Respiratory Support Need in Hospitalized Exacerbation of Chronic Obstructive Lung Disease Patients Medical Principles and Practice DOI 10.1159/000538812 YÖKSİS SJR Q1 JCR Q2
  10. 2024 Impact of Baseline Patient Characteristics on Short- and Long-Term Overall Mortality in Elderly Patients with COVID-19: A Retrospective Cohort Study Geriatrik Bilimler Dergisi DOI 10.47141/geriatrik.1460339 YÖKSİS TR Index
  11. 2023 Elderly idiopathic pulmonary fibrosis patients remain on therapy despite higher incidence of adverse events and dose reductions Elsevier BV DOI 10.1016/j.resinv.2023.04.007 YÖKSİS SJR Q2 JCR Q2 OpenAlex 87.1%
  12. 2023 Response to “Hypercapnic respiratory failure with insufficient response to fixedlevel PS-NIV: Is AVAPS the end solution?” Bilimsel Tip Publishing House DOI 10.5578/tt.20239924 YÖKSİS TR Index SJR Q3 JCR Q4
  13. 2023 Different Cases, Different Manifestations of Post-COVID-19 Retinal Artery Occlusion: A Case Series. Turkish journal of ophthalmology DOI 10.4274/tjo.galenos.2022.36930 YÖKSİS SJR Q2
  14. 2023 Development and validation of a simple risk scoring system for a COVID-19 diagnostic prediction model TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX DOI 10.5578/tt.20239601 2 YÖKSİS kaydı YÖKSİS TR Index SJR Q3 JCR Q4
  15. 2022 SD-OCT assessment of macular and optic nerve alterations in patients recovered from COVID-19 Canadian Journal of Ophthalmology DOI doi: 10.1016/j.jcjo.2021.06.019 YÖKSİS SJR Q2 JCR Q1
  16. 2022 Characteristics and outcomes of COVID-19 patients with IPF: a multi-center retrospective study Respiratory Medicine and Research DOI 10.1016/j.resmer.2022.100900 YÖKSİS SJR Q3 JCR Q4
  17. 2022 Serum Krebs von den Lungen-6: Promising biomarker to differentiate CPFE from IPF SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES DOI 10.36141/svdld.v39i4.11344 YÖKSİS SJR Q2 JCR Q4
  18. 2022 Prognostic factors for COVID-19 patients The Journal of Infection in Developing Countries DOI https://www.jidc.org/index.php/journal YÖKSİS SJR Q3 JCR Q4
  19. 2022 A Pilot Study for IgE as a Prognostic Biomarker in COVID-19 Internal Medicine Journal DOI 10.1111/imj.15728 YÖKSİS SJR Q3 JCR Q3
  20. 2022 Long‐term oxygen treatment need is less frequent in eosinophilic COPD patients Clin Respir J DOI 10.1111/crj.13451 YÖKSİS SJR Q3 JCR Q4 OpenAlex 40.7%

Akademisyenlere dön